Reactive microglia rapidly upregulate pro-inflammatory cytokines to damaged retinas (Todd et al., 2019), and these cytokines activate NFκB signaling in MG, which, in turn, suppresses the neurogenic potential of Ascl1-overexpressing MG (Palazzo et al., 2022). This evidence concerns the gene NFKB1 and myasthenia gravis.